Global /Hong Kong /Healthcare /Drug Manufacturers - Specialty & Generic /6893
chevron_leftBack
Hin Sang Group (International) Holding Co. Ltd. logo

Hin Sang Group (International) Holding Co. Ltd.

6893
SHEK: 6893 Delayed
0.1200HKD 3.5%
0.0153 USD
As of 7 June 2026, Hin Sang Group (International) Holding Co. Ltd. has a market cap of $16.16M USD, ranking #38526 globally and #1149 in Hong Kong. It ranks #3435 in the Healthcare sector, and #220 in the Drug Manufacturers - Specialty & Generic industry.
Global Rank
38526
Country Rank
1149
Sector Rank
3435
Industry Rank
220
Key Stats
Market Cap
$16.16MUSD
126.65M HKD
Enterprise Value
$58.34MUSD
457.12M HKD
Revenue (TTM)
$12.19MUSD
95.53M HKD
EBITDA (TTM)
-$765.36KUSD
-6.0M HKD
Net Income (TTM)
-$5.12MUSD
-40.1M HKD
EBITDA Margin
-6.3%
Profit Margin
-42%
PS Ratio
1.3
PB Ratio
0.9
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Lai Man Kwan open_in_new
Employees
185
Founded
1996
Website
hinsanggroup.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
3.5% -20% -46% -60% -38% -33%
Upcoming Earnings
Earnings Date
Fri, Jun 26

News

Loading...

Markets

Exchange Ticker Price
Hong Kong Stock Exchange
MIC: XHKG
PRIMARY
6893
衍生集團(國際)控股有限公司
ISIN: KYG4590V1023
Shares Out.:
1.092B1 Shares Float: 520.615M2
TV:
SA:
YF:
GF:
BA:
MS:
0.1200 HKD
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Hin Sang Group (International) Holding Co. Ltd.

Hin Sang Group (International) Holding Co. Ltd., together with its subsidiaries, engages in the manufacture, marketing, and sale of healthcare products for children in Hong Kong and Mainland China. It operates in four segments: Product Development, Brand Development and Management, Trading of Goods, and Healthcare. The Product Development segment develops and sells personal care products, household products, and health supplements under the Hin Sang, Tai Wo Tong, Yabune, Weverse, Care Plus, and King’s Antiseptic brands. Its Brand Development and Management segment engages in marketing, selling and distribution, logistics, and delivery services of personal care products; and manages and develops brands for its brand proprietors. The Trading of Goods segment engages in the trading, distribution, and sale of skin care products, personal care products, and household products purchased from various authorized dealers, independent traders, manufacturers, parallel importers, and suppliers. Its Healthcare segment engages in the provision of Chinese medical healthcare, including medical treatment and consultation by Chinese physicians for mothers and children; and the development of mother and child-related health products, medical centers, and related services. The company is also involved in property and investment holding activities. It serves retailers and distributors, and directly to customers through its retail outlets and online channel. The company was founded in 1996 and is headquartered in Tsim Sha Tsui, Hong Kong. Hin Sang Group (International) Holding Co. Ltd. is a subsidiary of Genwealth Group Holding Company Limited.

Similar Companies

Industry: Drug Manufacturers - Specialty & Generic (Hong Kong)
Name
Market Cap diff.
PE
$1.2B
9.41B HKD
7K%
42.9
$883.19M
6.92B HKD
5K%
-
$291.03M
2.28B HKD
2K%
7.5
$256.61M
2.01B HKD
1K%
10.0
$45.51M
356.6M HKD
182%
-
GBLP
$20.76M
28%
-
Industry: Drug Manufacturers - Specialty & Generic (Global)
Name
Market Cap diff.
PE
$37.66B
108.92B ILS
233K%
24.2
$29.56B
183K%
-
$15.86B
107.34B CNY
98K%
16.0
CIPLA
$11.12B
1.06T INR
69K%
23.4
LUPIN
$11.0B
1.05T INR
68K%
22.7
$9.1B
61.6B CNY
56K%
80.6
chevron_leftBack